Skip to product information
1 of 1

GeneBio Systems

IPO7 Polyclonal Antibody

IPO7 Polyclonal Antibody

SKU:E-AB-16521

Regular price €490,95 EUR
Regular price Sale price €490,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: IPO7

Target Synonym: FLJ14581;Imp 7;Imp7;Importin-7;Importin7;IPO 7;IPO7;IPO7;MGC138673;Ran binding protein 7;Ran-binding protein 7;RANBP 7;RanBP7

Research Areas: Cancer;Epigenetics and Nuclear Signaling;Signal transduction

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: WB;IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: O95373

Accession:

Background: The importin-alpha/beta complex and the GTPase Ran mediate nuclear import of proteins with a classical nuclear localization signal. The protein encoded by this gene is a member of a class of approximately 20 potential Ran targets that share a sequence motif related to the Ran-binding site of importin-beta. Similar to importin-beta, this protein prevents the activation of Ran's GTPase by RanGAP1 and inhibits nucleotide exchange on RanGTP, and also binds directly to nuclear pore complexes where it competes for binding sites with importin-beta and transportin. This protein has a Ran-dependent transport cycle and it can cross the nuclear envelope rapidly and in both directions. At least four importin beta-like transport receptors, namely importin beta itself, transportin, RanBP5 and RanBP7, directly bind and import ribosomal proteins.

Concentration: 0.5 mg/mL

Immunogen: Synthetic peptide of human IPO7

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: WB 1:500-1:2000;IHC 1:100-1:300

Calculated MW: 120kDa

ObservedMW:

View full details